Press Release Distribution Service Login or Sign Up • Login • Lost Password • Sign Up
• New Press Release • For Journalists • News Categories
Recent Study Explores Thyroid Cancer Pipeline Review, H2 2017 Thursday, September 14th, 2017 - WiseGuyReports
SUMMARY WiseGuyReports published new report, titled “Thyroid Cancer - Pipeline Review, H2”. Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer - Pipeline Review, H2 2017, provides an overview of the Thyroid Cancer (Oncology) pipeline landscape. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include lump that can be felt through the skin on neck, difficulty swallowing, pain in neck and throat and swollen lymph nodes in neck. Predisposing factors include female, high levels of radiation and inherited genetic syndromes. Treatment includes surgery and thyroid hormone therapy.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2258231-thyroid-
cancer-pipeline-review-h2-2017 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Thyroid Cancer - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Thyroid Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 3, 33, 28, 1, 11 and 3 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 3 and 5 molecules, respectively. Thyroid Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Thyroid Cancer (Oncology). - The pipeline guide reviews pipeline therapeutics for Thyroid Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Thyroid Cancer (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Thyroid Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Thyroid Cancer (Oncology)
Key points to buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Thyroid Cancer (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Thyroid Cancer (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents Table of Contents Introduction Thyroid Cancer - Overview Thyroid Cancer - Therapeutics Development Thyroid Cancer - Therapeutics Assessment Thyroid Cancer - Companies Involved in Therapeutics Development Thyroid Cancer - Drug Profiles Thyroid Cancer - Dormant Projects
..CONTINUED About Us Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us Email Us at : [email protected] Reach Us at : +1 339 368 6938 (US) +44 208 133 9349 (UK)
For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check https://www.wiseguyreports.com/conferences
For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check https://www.wiseguyreports.com/seminars
Contact Profile WiseGuyReports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every
market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations. Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.
Norah Trent P: +44 208 133 9349 M: +1 646 845 9349 W: www.wiseguyreports.com/
Keywords Thyroid Cancer, THYROID CANCER Services, Thyroid Cancer Services, THYROID CANCER analysis, THYROID CANCER Services, Europe Thyroid Cancer, THYROID CANCER outlook
Newsrooms • WiseGuyReports
Sharing More Formats View QR Code
Quick Links • New Press Release • For Journalists • News Categories
Company • • • •
Contact About Terms Pricing
• Privacy
We're Social • • • • •
Blog Twitter Facebook LinkedIn Google+
Subscribe Subscribe to receive NewsMaker E-News updates with the latest PR tips and trends Subscribe Copyright© 2005-2017 Newsgallery Pty Ltd. NewsMaker® is a trademark of NewsGallery Pty Ltd. 2017-09-14 20:13:32 GMT +9.5
Back to Top